Aurinia Pharmaceuticals (AUPH)
Markets LUPKYNIS for lupus nephritis and develops additional autoimmune therapies.
$16.29
Pre-market−0.01 (−0.06%)
At close$16.30(+1.56%)
Something off on this page? Send us feedback.
Next report
Nov 3, 2026
estimated · in 61 days
EPS estimate
$0.19
Revenue estimate
$83.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Jul '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.09$0.16$0.16$0.23$0.26$0.25$0.28Pending
Estimate$0.03$0.08$0.17$0.16$0.21$0.18$0.24$0.19
Surprise+200.0%+100.0%−5.9%+43.8%+23.8%+38.9%+16.7%—
RevenueReportedEstimate
Feb '25May '25Jul '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$59.9M$62.5M$70.0M$73.5M$77.1M$77.7M$83.2MPending
Estimate$61.8M$64.6M$67.7M$74.7M$74.7M$77.0M$80.4M$83.6M
Surprise−3.2%−3.4%+3.4%−1.6%+3.2%+0.9%+3.4%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.19 | — | — |
| Aug 2026 | $0.24 | $0.28 | +16.7% |
| May 2026 | $0.18 | $0.25 | +38.9% |
| Feb 2026 | $0.21 | $0.26 | +23.8% |
| Nov 2025 | $0.16 | $0.23 | +43.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Jan 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Jan 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | $0.19 | — | — | $83.6M | — | — | — |
| Aug 6, 2026 | $0.24 | $0.28 | +16.7% | $80.4M | $83.2M | +3.4% | +6.2% |
| May 7, 2026 | $0.18 | $0.25 | +38.9% | $77.0M | $77.7M | +0.9% | +0.6% |
| Feb 26, 2026 | $0.21 | $0.26 | +23.8% | $74.7M | $77.1M | +3.2% | +1.4% |
| Nov 4, 2025 | $0.16 | $0.23 | +43.8% | $74.7M | $73.5M | −1.6% | +1.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Jul 31, 2025 | |||||||
| May 12, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 2, 2024 | |||||||
| Feb 15, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 10, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 24, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 11, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 5, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 14, 2019 | |||||||
| Jan 22, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 15, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 10, 2017 | |||||||
| May 15, 2017 | |||||||
| Jan 3, 2017 | |||||||
| Nov 4, 2016 | |||||||
| Aug 5, 2016 | |||||||
| May 11, 2016 | |||||||
| Mar 18, 2016 | |||||||
| Nov 13, 2015 | |||||||
| Aug 11, 2015 | |||||||